Atlas Trials

Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma

Clinical trial NCT04322643 · TERMINATED

Trial details

NCT number
NCT04322643
Sponsor
Case Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Carcinoma
Start date
2020-03-23
Primary completion
2022-08-08
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.